![](https://amniotechnology.com/wp-content/uploads/2022/12/Amnio-Technology-SPEC-LOGO-002.2.0-1-300x140.png)
Amnio Technology was founded in 2012 and is focused on optimizing the regenerative potential and clinical use of amniotic tissue.
PalinGen® products do not require fetal sacrifice and recovery is performed with maternal consent during elective Cesarean delivery.
Manufacture of PalinGen® Membrane, Hydromembrane, XPlus Membrane, and XPlus Hydromembrane.
![](https://amniotechnology.com/wp-content/uploads/2023/05/Exterior-flagpole.jpg)
10+
Years of Experience